These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20164291)

  • 21. Changes in adiponectin and inflammatory genes in response to hormonal imbalances in female mice and exacerbation of depot selective visceral adiposity by high-fat diet: implications for insulin resistance.
    Zhang H; Chen X; Aravindakshan J; Sairam MR
    Endocrinology; 2007 Dec; 148(12):5667-79. PubMed ID: 17717050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-birth weight children develop lower sex hormone binding globulin and higher dehydroepiandrosterone sulfate levels and aggravate their visceral adiposity and hypoadiponectinemia between six and eight years of age.
    Ibáñez L; Lopez-Bermejo A; Díaz M; Suárez L; de Zegher F
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3696-9. PubMed ID: 19737922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low serum adiponectin levels in subjects born small for gestational age: impact on insulin sensitivity.
    Jaquet D; Deghmoun S; Chevenne D; Czernichow P; Lévy-Marchal C
    Int J Obes (Lond); 2006 Jan; 30(1):83-7. PubMed ID: 16231036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.
    Addy CL; Gavrila A; Tsiodras S; Brodovicz K; Karchmer AW; Mantzoros CS
    J Clin Endocrinol Metab; 2003 Feb; 88(2):627-36. PubMed ID: 12574192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies.
    Shetty S; Kusminski CM; Scherer PE
    Trends Pharmacol Sci; 2009 May; 30(5):234-9. PubMed ID: 19359049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of chronic hyperinsulinemia on plasma adiponectin levels in Sprague-Dawley rats.
    Kamari Y; Peleg E; Herman MO; Bursztyn M; Grossman E; Sharabi Y
    Horm Metab Res; 2009 Jan; 41(1):46-9. PubMed ID: 18949682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents.
    Balagopal P; George D; Yarandi H; Funanage V; Bayne E
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6192-7. PubMed ID: 16131584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
    Yamauchi T; Kadowaki T
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipokines regulate systemic insulin sensitivity in accordance to existing energy reserves.
    Huypens P
    Med Hypotheses; 2007; 69(1):161-5. PubMed ID: 17208384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome.
    Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.
    Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K; Tobe K
    J Clin Invest; 2006 Jul; 116(7):1784-92. PubMed ID: 16823476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
    Matsuda M; Shimomura I
    Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating adiponectin and adiponectin receptor expression in skeletal muscle: effects of exercise.
    Vu V; Riddell MC; Sweeney G
    Diabetes Metab Res Rev; 2007 Nov; 23(8):600-11. PubMed ID: 17966120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin in diabetes mellitus.
    Xita N; Tsatsoulis A
    Curr Med Chem; 2012; 19(32):5451-8. PubMed ID: 22876922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.
    Li L; Yang G; Li Q; Tang Y; Li K
    Ann Nutr Metab; 2006; 50(6):499-505. PubMed ID: 17191023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardioprotection by adiponectin.
    Ouchi N; Shibata R; Walsh K
    Trends Cardiovasc Med; 2006 Jul; 16(5):141-6. PubMed ID: 16781946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M; Kanno H; Tomono Y; Inaba S; Senba I; Furuno M; Mogi M; Horiuchi M
    J Hypertens; 2010 Jul; 28(7):1471-81. PubMed ID: 20543712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease.
    Menzaghi C; Trischitta V; Doria A
    Diabetes; 2007 May; 56(5):1198-209. PubMed ID: 17303804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
    Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
    Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.